{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:40:07Z","timestamp":1793900407731,"version":"4.8.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T00:00:00Z","timestamp":1712448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R00DK120875"],"award-info":[{"award-number":["R00DK120875"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.isci.2024.109709","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T22:48:33Z","timestamp":1712702913000},"page":"109709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and de novo lipogenesis"],"prefix":"10.1016","volume":"27","author":[{"given":"Noble Kumar","family":"Talari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ushodaya","family":"Mattam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Kaminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Sotomayor-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afra P.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"P\u00e9terfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Pajukanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Pihlajam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4895-2495","authenticated-orcid":false,"given":"Karthickeyan","family":"Chella Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.109709_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2024.109709_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0884533611419668","article-title":"Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy","volume":"26","author":"Kopec","year":"2011","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.isci.2024.109709_bib4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2024.109709_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2001-12926","article-title":"Clinical features and natural history of nonalcoholic steatosis syndromes","volume":"21","author":"Falck-Ytter","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.isci.2024.109709_bib6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","article-title":"Gender and racial differences in nonalcoholic fatty liver disease","volume":"6","author":"Pan","year":"2014","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.isci.2024.109709_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/gast.2003.50004","article-title":"Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States","volume":"124","author":"Ruhl","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2024.109709_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.isci.2024.109709_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1572-0241.2005.00341.x","article-title":"The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002","volume":"101","author":"Ioannou","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.isci.2024.109709_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"178","author":"Lazo","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.isci.2024.109709_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/oby.20426","article-title":"Racial differences in nonalcoholic fatty liver disease in the U.S. population","volume":"22","author":"Schneider","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.isci.2024.109709_bib13","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Non-alcoholic fatty liver disease: the mist gradually clears","volume":"48","author":"de Alwis","year":"2008","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.109709_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","article-title":"The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease","volume":"8","author":"McCullough","year":"2004","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.isci.2024.109709_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cels.2017.12.006","article-title":"Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease","volume":"6","author":"Chella Krishnan","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.isci.2024.109709_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00125-006-0489-8","article-title":"Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes","volume":"50","author":"Misu","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2024.109709_bib17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00125-004-1366-y","article-title":"Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients","volume":"47","author":"Takamura","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2024.109709_bib18","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.metabol.2006.06.016","article-title":"Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line","volume":"55","author":"Takeshita","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.isci.2024.109709_bib19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","article-title":"Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism","volume":"22","author":"Meex","year":"2015","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2014.06.010","article-title":"The PPARalpha-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway","volume":"20","author":"Vernia","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A liver-derived secretory protein, selenoprotein P, causes insulin resistance","volume":"12","author":"Misu","year":"2010","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-5793(83)80791-1","article-title":"Inter-alpha-trypsin-inhibitor (ITI): two distinct mRNAs in baboon liver argue for a discrete synthesis of ITI and ITI derivatives","volume":"162","author":"Bourguignon","year":"1983","journal-title":"FEBS Lett."},{"key":"10.1016\/j.isci.2024.109709_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1432-1327.1998.2520339.x","article-title":"Inter-alpha-trypsin inhibitor proteoglycan family--a group of proteins binding and stabilizing the extracellular matrix","volume":"252","author":"Bost","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.isci.2024.109709_bib24","doi-asserted-by":"crossref","first-page":"28282","DOI":"10.1016\/S0021-9258(18)46925-6","article-title":"Proteins of the inter-alpha-trypsin inhibitor family stabilize the cumulus extracellular matrix through their direct binding with hyaluronic acid","volume":"269","author":"Chen","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.109709_bib25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.18388\/abp.2003_3664","article-title":"Inter-alpha-inhibitor, hyaluronan and inflammation","volume":"50","author":"Fries","year":"2003","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.isci.2024.109709_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF01753978","article-title":"Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion","volume":"12","author":"Kobayashi","year":"1994","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.isci.2024.109709_bib27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1515\/bchm3.1987.368.2.963","article-title":"cDNA cloning of human inter-alpha-trypsin inhibitor discloses three different proteins","volume":"368","author":"Schreitm\u00fcller","year":"1987","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"10.1016\/j.isci.2024.109709_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/37995","article-title":"Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1","volume":"389","author":"Gomis-R\u00fcth","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109709_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(88)80025-4","article-title":"Plasminogen activator dependent pathways inthe dissemination of human tumor cells in the chick embryo","volume":"52","author":"Ossowski","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.109709_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4735","article-title":"Overproduction of inter-alpha-trypsin inhibitor heavy chain 1 after loss of Galpha(13) in liver exacerbates systemic insulin resistance in mice","volume":"11","author":"Kim","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2024.109709_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s12885-019-5825-8","article-title":"Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study","volume":"19","author":"Nakamura","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2024.109709_bib32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.22123","article-title":"Comprehensive and quantitative proteome profiling of the mouse liver and plasma","volume":"47","author":"Lai","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","article-title":"Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target","volume":"7","author":"Wang","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.isci.2024.109709_bib34","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.23837","article-title":"Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3","volume":"52","author":"Ki","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jhep.2010.03.004","article-title":"Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22","volume":"53","author":"Yang","year":"2010","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.109709_bib36","series-title":"Lrg1 Inhibits the Activation of Hepatic Macrophages to Alleviate NAFLD by Enhancing TGF-\u03921 Signaling","author":"Xu","year":"2022"},{"key":"10.1016\/j.isci.2024.109709_bib37","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61","author":"Zhang","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.109709_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046584","article-title":"Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis","volume":"7","author":"Starmann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.109709_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05607","article-title":"The genetic architecture of NAFLD among inbred strains of mice","volume":"4","author":"Hui","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.isci.2024.109709_bib40","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.30113","article-title":"The Genetic Architecture of Diet-Induced Hepatic Fibrosis in Mice","volume":"68","author":"Hui","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2024.109709_bib42","doi-asserted-by":"crossref","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene Suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109709_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101134","article-title":"Mitochondrial oxidative function in NAFLD: Friend or foe?","volume":"50","author":"Shum","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jcmgh.2020.09.004","article-title":"Liver Pyruvate Kinase Promotes NAFLD\/NASH in Both Mice and Humans in a Sex-Specific Manner","volume":"11","author":"Chella Krishnan","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2024.109709_bib45","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.30765","article-title":"Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice","volume":"70","author":"Gluchowski","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib46","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/s41591-021-01489-1","article-title":"ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials","volume":"27","author":"Calle","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.109709_bib47","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.ymthe.2021.11.007","article-title":"An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis","volume":"30","author":"Yenilmez","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2024.109709_bib48","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hep.29025","article-title":"Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"65","author":"McCommis","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib49","article-title":"Mitochondrial Pyruvate Carrier Inhibition Attenuates Hepatic Stellate Cell Activation and Liver Injury in a Mouse Model of Metabolic Dysfunction-associated Steatotic Liver Disease","author":"Habibi","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2024.109709_bib50","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cmet.2015.07.028","article-title":"Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling","volume":"22","author":"McCommis","year":"2015","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144444","article-title":"The Signal Transducer and Activator of Transcription 1 (STAT1) Inhibits Mitochondrial Biogenesis in Liver and Fatty Acid Oxidation in Adipocytes","volume":"10","author":"Sisler","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.109709_bib52","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.21419","article-title":"STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity","volume":"44","author":"Jeong","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib53","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/gutjnl-2019-318372","article-title":"Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells","volume":"69","author":"Mart\u00ed-Rodrigo","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.isci.2024.109709_bib54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2024.109709_bib55","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/nmeth.1436","article-title":"Visualization of omics data for systems biology","volume":"7","author":"Gehlenborg","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2024.109709_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrg3575","article-title":"Systems genetics approaches to understand complex traits","volume":"15","author":"Civelek","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.isci.2024.109709_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14789450.4.2.239","article-title":"Approaches to the study of the cell secretome","volume":"4","author":"Hathout","year":"2007","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.isci.2024.109709_bib58","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1074\/mcp.M600265-MCP200","article-title":"Characterization of the human visceral adipose tissue secretome","volume":"6","author":"Alvarez-Llamas","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.isci.2024.109709_bib59","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.jprot.2010.07.001","article-title":"Secretome proteomics for discovery of cancer biomarkers","volume":"73","author":"Makridakis","year":"2010","journal-title":"J.\u00a0Proteonomics"},{"key":"10.1016\/j.isci.2024.109709_bib60","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/pr8008572","article-title":"Pathway-based biomarker search by high-throughput proteomics profiling of secretomes","volume":"8","author":"Lawlor","year":"2009","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.isci.2024.109709_bib61","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.cmet.2018.03.015","article-title":"A Strategy for Discovery of Endocrine Interactions with Application to Whole-Body Metabolism","volume":"27","author":"Seldin","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib62","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3390\/ijms21072296","article-title":"Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH)","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.109709_bib63","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20188793","article-title":"Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease","volume":"15","author":"Niu","year":"2019","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.isci.2024.109709_bib64","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1002\/pmic.201000391","article-title":"Plasma proteome analysis in diet-induced obesity-prone and obesity-resistant rats","volume":"10","author":"Choi","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.isci.2024.109709_bib65","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nm1214","article-title":"Angiopoietin-related growth factor antagonizes obesity and insulin resistance","volume":"11","author":"Oike","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.109709_bib66","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","article-title":"NASH: a mitochondrial disease","volume":"42","author":"Pessayre","year":"2005","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.109709_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.isci.2024.109709_bib68","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib69","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib70","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/db08-1074","article-title":"Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver","volume":"58","author":"Kotronen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2024.109709_bib71","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/hep.25932","article-title":"Elovl6 promotes nonalcoholic steatohepatitis","volume":"56","author":"Matsuzaka","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.109709_bib72","first-page":"505","article-title":"Expression of fatty acid synthase in nonalcoholic fatty liver disease","volume":"3","author":"Dorn","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.isci.2024.109709_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferr\u00e9","year":"2010","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13733","article-title":"De novo lipogenesis in non-alcoholic fatty liver disease: Quantification with stable isotope tracers","volume":"52","author":"Belew","year":"2022","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.isci.2024.109709_bib75","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fcell.2019.00248","article-title":"Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome","volume":"7","author":"Knebel","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2024.109709_bib76","first-page":"520","article-title":"Conversion of Sugar to Fat: Is Hepatic de Novo Lipogenesis Leading to Metabolic Syndrome and Associated Chronic Diseases?","volume":"117","author":"Schwarz","year":"2017","journal-title":"J.\u00a0Am. Osteopath. Assoc."},{"key":"10.1016\/j.isci.2024.109709_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.06.010","article-title":"STAT3: A key regulator in liver fibrosis","volume":"21","author":"Zhao","year":"2021","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.isci.2024.109709_bib78","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep4.1413","article-title":"Novel Lipid Long Intervening Noncoding RNA, Oligodendrocyte Maturation-Associated Long Intergenic Noncoding RNA, Regulates the Liver Steatosis Gene Stearoyl-Coenzyme A Desaturase As an Enhancer RNA","volume":"3","author":"Benhammou","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.isci.2024.109709_bib79","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hep4.1630","article-title":"Protein Phosphatase 1 Regulatory Subunit 3B Genotype at rs4240624 Has a Major Effect on Gallbladder Bile Composition","volume":"5","author":"M\u00e4nnist\u00f6","year":"2021","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.isci.2024.109709_bib80","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","article-title":"Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation","volume":"40","author":"McCarthy","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109709_bib81","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molmet.2019.09.009","article-title":"Sex-specific metabolic functions of adipose Lipocalin-2","volume":"30","author":"Chella Krishnan","year":"2019","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib82","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/s42255-021-00481-w","article-title":"Sex-specific genetic regulation of adipose mitochondria and metabolic syndrome by Ndufv2","volume":"3","author":"Chella Krishnan","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.isci.2024.109709_bib83","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1101\/gr.099234.109","article-title":"A high-resolution association mapping panel for the dissection of complex traits in mice","volume":"20","author":"Bennett","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.isci.2024.109709_bib84","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cmet.2015.01.002","article-title":"Genetic architecture of insulin resistance in the mouse","volume":"21","author":"Parks","year":"2015","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.109709_bib85","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.109709_bib86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.109709_bib87","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.12688\/f1000research.7035.1","article-title":"RNA-Seq workflow: gene-level exploratory analysis and differential expression","volume":"4","author":"Love","year":"2015","journal-title":"F1000Res."},{"key":"10.1016\/j.isci.2024.109709_bib88","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.isci.2024.109709_bib89","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.isci.2024.109709_bib90","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224009313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224009313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:24:12Z","timestamp":1783473852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224009313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2589004224009313"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.109709","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and de novo lipogenesis","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.109709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109709"}}